MP
BIOSW

Mangrove Partners’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Mangrove Partners’s Portfolio BIOSW Stock Details BIOSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-341,144
Closed -$3.56M – 254
2023
Q1 		$3.56M Sell
341,144
-28,145
-8% -$2.27K 0.23% 140
2022
Q4 		$3.77M Buy
+369,289
New +$18.9K 0.21% 172
2022
Q3 		– Sell
-202,570
Closed -$2.01M – 515
2022
Q2 		$2.01M Buy
+202,570
New +$37.8K 0.1% 297

Other funds holding BIOSW

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Mangrove Partners's BIOSW Position: Q2 2023 in Review

Mangrove Partners sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q2 2023, closing a stake of 341,144 shares — an estimated $3.56M sold.

Mangrove Partners first reported a position in BIOSW in Q2 2022 and held it in 3 quarters. The position peaked at $3.77M in Q4 2022. 44 funds tracked by Wall St. Rank hold BIOSW as of Q2 2023.

  • Mangrove Partners reported no remaining BioPlus Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Mangrove Partners sold 341,144 BioPlus Acquisition Corp. Warrants shares in Q2 2023, an estimated $3.56M.
  • Mangrove Partners first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 3 quarters.
  • Mangrove Partners's BioPlus Acquisition Corp. Warrants position peaked at $3.77M in Q4 2022.
  • 44 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q2 2023.

Based on Mangrove Partners's 13F filing for Q2 2023, filed 14 Aug 2023.